145 results on '"Li, Jing-Xin"'
Search Results
2. Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial
3. Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
4. Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B
5. Effects of different conditioning parameters on aroma components of tobacco leaves
6. Narrow and wide India–Burma trough-like circulations: their different impacts on precipitation over southern China
7. Survey of Human Identification Algorithms Based on Wi-Fi Signal
8. Inhibition of gut bacterial β-glucuronidase by chemical components from black tea: Inhibition interactions and molecular mechanism
9. Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
10. Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials
11. Fermion Resonances on Multi-field Thick Branes
12. A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
13. Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
14. Machine Learning–Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study
15. Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial
16. Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens
17. A putative α-glucoside transporter gene BbAGT1 contributes to carbohydrate utilization, growth, conidiation and virulence of filamentous entomopathogenic fungus Beauveria bassiana
18. Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis
19. Regioselective hydroxylation of carbendazim by mammalian cytochrome P450: A combined experimental and computational study
20. Identification of Escherichia coli β-glucuronidase inhibitors from Polygonum cuspidatum Siebold & Zucc.
21. Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19.
22. Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines
23. Coronavirus disease 2019 vaccines: landscape of global studies and potential risks
24. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial
25. How to understand the efficacy measurements for enterovirus type 71 vaccine?
26. Amentoflavone from Selaginella tamariscina as a potent inhibitor of gut bacterial β-glucuronidase: Inhibition kinetics and molecular dynamics stimulation
27. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials
28. The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
29. A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
30. Progress on the research and development of inactivated EV71 whole-virus vaccines
31. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children An open label, phase 1 clinical trial
32. Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
33. High salt-induced weakness of anti-oxidative function of natriuretic peptide receptor-C and podocyte damage in the kidneys of Dahl rats
34. The vaccines-associated Arthus reaction
35. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013–2014
36. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children
37. Disease burden of enterovirus 71 in rural central China: A community-based survey
38. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis
39. Evaluation of vaccine seroresponse rates and adverse event rates through Bayesian and frequentist methods
40. Safety and immunogenocity of a novel combinedHaemophilus influenzaetype b–Neisseria meningitidisserogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old
41. Shiga toxins induce autophagic cell death in intestinal epithelial cells via the endoplasmic reticulum stress pathway
42. Clinical progress for enterovirus 71 vaccines: what does the future hold?
43. How to understand the efficacy measurements for enterovirus type 71 vaccine?
44. Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
45. Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants
46. Distribution Patterns of Invasive Plants in Heilongjiang Province and the Impact Factors
47. Fermion resonances on multi-field thick branes
48. Safety and immunogenocity of a novel combined Haemophilus influenzae type b– Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
49. Safety and immunogenocity of a novel combined Haemophilus influenzaetype b–Neisseria meningitidisserogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old
50. Diurnal Temperature Range and Daily Emergency Room Admissions among the Elderly in Beijing, China.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.